186 related articles for article (PubMed ID: 32093886)
41. UDP-glucuronosyltransferase isoforms catalyzing glucuronidation of hydroxy-polychlorinated biphenyls in rat.
Daidoji T; Gozu K; Iwano H; Inoue H; Yokota H
Drug Metab Dispos; 2005 Oct; 33(10):1466-76. PubMed ID: 16006569
[TBL] [Abstract][Full Text] [Related]
42. Homo- and hetero-dimerization of human UDP-glucuronosyltransferase 2B7 (UGT2B7) wild type and its allelic variants affect zidovudine glucuronidation activity.
Yuan L; Qian S; Xiao Y; Sun H; Zeng S
Biochem Pharmacol; 2015 May; 95(1):58-70. PubMed ID: 25770680
[TBL] [Abstract][Full Text] [Related]
43. Effect of the acute phase response induced by endotoxin administration on the expression and activity of UGT isoforms in rats.
Alkharfy KM; Poloyac SM; Congiu M; Desmond PV; Frye RF
Drug Metab Lett; 2008 Dec; 2(4):248-55. PubMed ID: 19356101
[TBL] [Abstract][Full Text] [Related]
44. Activation of morphine glucuronidation by fatty acyl-CoAs and its plasticity: a comparative study in humans and rodents including chimeric mice carrying human liver.
Nurrochmad A; Ishii Y; Nakanoh H; Inoue T; Horie T; Sugihara K; Ohta S; Taketomi A; Maehara Y; Yamada H
Drug Metab Pharmacokinet; 2010; 25(3):262-73. PubMed ID: 20610885
[TBL] [Abstract][Full Text] [Related]
45. Alteration of the function of the UDP-glucuronosyltransferase 1A subfamily by cytochrome P450 3A4: different susceptibility for UGT isoforms and UGT1A1/7 variants.
Ishii Y; Koba H; Kinoshita K; Oizaki T; Iwamoto Y; Takeda S; Miyauchi Y; Nishimura Y; Egoshi N; Taura F; Morimoto S; Ikushiro S; Nagata K; Yamazoe Y; Mackenzie PI; Yamada H
Drug Metab Dispos; 2014 Feb; 42(2):229-38. PubMed ID: 24255116
[TBL] [Abstract][Full Text] [Related]
46. The UDP-glucuronosyltransferase 2B7 isozyme is responsible for gemfibrozil glucuronidation in the human liver.
Mano Y; Usui T; Kamimura H
Drug Metab Dispos; 2007 Nov; 35(11):2040-4. PubMed ID: 17670842
[TBL] [Abstract][Full Text] [Related]
47. Substrate-dependent modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1) by propofol in recombinant human UGT1A1 and human liver microsomes.
Mano Y; Usui T; Kamimura H
Basic Clin Pharmacol Toxicol; 2007 Sep; 101(3):211-4. PubMed ID: 17697043
[TBL] [Abstract][Full Text] [Related]
48. UDP-glucuronosyltransferase, the role of the amino terminus in dimerization.
Meech R; Mackenzie PI
J Biol Chem; 1997 Oct; 272(43):26913-7. PubMed ID: 9341125
[TBL] [Abstract][Full Text] [Related]
49. Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity: relationship between UGT1A1 promoter genotype and variability in a liver bank.
Fisher MB; Vandenbranden M; Findlay K; Burchell B; Thummel KE; Hall SD; Wrighton SA
Pharmacogenetics; 2000 Nov; 10(8):727-39. PubMed ID: 11186135
[TBL] [Abstract][Full Text] [Related]
50. Effects of cyclophosphamide and adriamycin on rat hepatic microsomal glucuronidation and lipid peroxidation.
Lear L; Nation RL; Stupans I
Biochem Pharmacol; 1992 Aug; 44(4):747-53. PubMed ID: 1510722
[TBL] [Abstract][Full Text] [Related]
51. In vitro glucuronidation of the primary metabolite of 10-chloromethyl-11-demethyl-12-oxo-calanolide A by human liver microsomes and its interactions with UDP-glucuronosyltransferase substrates.
Liu X; Sheng L; Zhao M; Mi J; Liu Z; Li Y
Drug Metab Pharmacokinet; 2015 Feb; 30(1):89-96. PubMed ID: 25760535
[TBL] [Abstract][Full Text] [Related]
52. Human and rat liver UDP-glucuronosyltransferases are targets of ketoprofen acylglucuronide.
Terrier N; Benoit E; Senay C; Lapicque F; Radominska-Pandya A; Magdalou J; Fournel-Gigleux S
Mol Pharmacol; 1999 Jul; 56(1):226-34. PubMed ID: 10385704
[TBL] [Abstract][Full Text] [Related]
53. Effect of spironolactone on the expression of rat hepatic UDP-glucuronosyltransferase.
Catania VA; Luquita MG; Sánchez Pozzi EJ; Ikushiro S; Emi Y; Iyanagi T; Mottino AD
Biochem Pharmacol; 2003 Jul; 66(1):171-7. PubMed ID: 12818378
[TBL] [Abstract][Full Text] [Related]
54. Effect of chronic renal insufficiency on hepatic and renal udp-glucuronyltransferases in rats.
Yu C; Ritter JK; Krieg RJ; Rege B; Karnes TH; Sarkar MA
Drug Metab Dispos; 2006 Apr; 34(4):621-7. PubMed ID: 16415115
[TBL] [Abstract][Full Text] [Related]
55. In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicin.
Fisher MB; Campanale K; Ackermann BL; VandenBranden M; Wrighton SA
Drug Metab Dispos; 2000 May; 28(5):560-6. PubMed ID: 10772635
[TBL] [Abstract][Full Text] [Related]
56. Identification of human UDP-glucuronosyltransferase responsible for the glucuronidation of niflumic acid in human liver.
Mano Y; Usui T; Kamimura H
Pharm Res; 2006 Jul; 23(7):1502-8. PubMed ID: 16783480
[TBL] [Abstract][Full Text] [Related]
57. The carboxyl-terminal di-lysine motif is essential for catalytic activity of UDP-glucuronosyltransferase 1A9.
Miyauchi Y; Kurohara K; Kimura A; Esaki M; Fujimoto K; Hirota Y; Takechi S; Mackenzie PI; Ishii Y; Tanaka Y
Drug Metab Pharmacokinet; 2020 Oct; 35(5):466-474. PubMed ID: 32883578
[TBL] [Abstract][Full Text] [Related]
58. Identification and characterization of human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of bergenin.
Song H; Wang J; Zhang R; Liu X; Yuan G; Wei C; Wang B; Guo R
Biomed Chromatogr; 2014 Mar; 28(3):348-53. PubMed ID: 23996546
[TBL] [Abstract][Full Text] [Related]
59. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform.
Ma L; Sun J; Peng Y; Zhang R; Shao F; Hu X; Zhu J; Wang X; Cheng X; Zhu Y; Wan P; Feng D; Wu H; Wang G
Drug Metab Dispos; 2012 Apr; 40(4):734-41. PubMed ID: 22238289
[TBL] [Abstract][Full Text] [Related]
60. Cloning and characterisation of the first drug-metabolising canine UDP-glucuronosyltransferase of the 2B subfamily.
Soars MG; Fettes M; O'Sullivan AC; Riley RJ; Ethell BT; Burchell B
Biochem Pharmacol; 2003 Apr; 65(8):1251-9. PubMed ID: 12694866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
